{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:55:08Z","timestamp":1778698508118,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>An ad hoc peer-review committee was jointly appointed by Drug Authorities and Industry in Germany, Austria and Switzerland in 1999\/2000 to review the evidence for a causal relation between phenacetin-free analgesics and nephropathy. The committee found the evidence as inconclusive and requested a new case-control study of adequate design.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a population-based case-control study with incident cases of end-stage renal disease (ESRD) under the age of 50 years and four age and sex-matched neighborhood controls in 170 dialysis centers (153 in Germany, and 17 in Austria) from January 1, 2001 to December 31, 2004. Data on lifetime medical history, risk factors, treatment, job exposure and intake of analgesics were obtained in a standardized face-to-face interview using memory aids to enhance accuracy. Study design, study performance, analysis plan, and study report were approved by an independent international advisory committee and by the Drug Authorities involved. Unconditional logistic regression analyses were performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The analysis included 907 cases and 3,622 controls who had never used phenacetin-containing analgesics in their lifetime. The use of high cumulative lifetime dose (3<jats:sup>rd<\/jats:sup> tertile) of analgesics in the period up to five years before dialysis was not associated with later ESRD. Adjusted odds ratios with 95% confidence intervals were 0.8 (0.7 \u2013 1.0) and 1.0 (0.8 \u2013 1.3) for ever- compared with no or low use and high use compared with low use, respectively. The same results were found for all analgesics and for mono-, and combination preparations with and without caffeine. No increased risk was shown in analyses stratifying for dose and duration. Dose-response analyses showed that analgesic use was not associated with an increased risk for ESRD up to 3.5 kg cumulative lifetime dose (98 % of the cases with ESRD). While the large subgroup of users with a lifetime dose up to 0.5 kg (278 cases and 1365 controls) showed a significantly decreased risk, a tiny subgroup of extreme users with over 3.5 kg lifetime use (19 cases and 11 controls) showed a significant risk increase. The detailed evaluation of 22 cases and 19 controls with over 2.5 kg lifetime use recommended by the regulatory advisors showed an impressive excess of other conditions than analgesics triggering the evolution of ESRD in cases compared with controls.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found no clinically meaningful evidence for an increased risk of ESRD associated with use of phenacetin-free analgesics in single or combined formulation. The apparent risk increase shown in a small subgroup with extreme lifetime dose of analgesics is most likely an indirect, non-causal association. This hypothesis, however, cannot be confirmed or refuted within our case-control study. Overall, our results lend support to the mounting evidence that phenacetin-free analgesics do not induce ESRD and that the notion of \"analgesic nephropathy\" needs to be re-evaluated.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-8-15","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T19:13:40Z","timestamp":1196882020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Analgesics use and ESRD in younger age: a case-control study"],"prefix":"10.1186","volume":"8","author":[{"given":"Fokke J","family":"van der Woude","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar AJ","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Moehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doerthe","family":"K\u00fchl-Habich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,5]]},"reference":[{"key":"91_CR1","first-page":"564","volume":"17","author":"O Sp\u00fchler","year":"1950","unstructured":"Sp\u00fchler O, Zollinger HU: Die chronische interstitielle Nephritis. Helv Med Acta. 1950, 17: 564-67.","journal-title":"Helv Med Acta"},{"key":"91_CR2","first-page":"297","volume":"34","author":"UC Dubach","year":"1968","unstructured":"Dubach UC, Levy PS, Minder F: Epidemiological study of analgesic intake and its relationship to urinary tract disorders in Switzerland. Helv Med Acta. 1968, 34: 297-312.","journal-title":"Helv Med Acta"},{"key":"91_CR3","first-page":"746","volume":"85","author":"HU Zollinger","year":"1955","unstructured":"Zollinger HU: Chronische interstitielle Nephritis bei Abusus von phenacetin-haltigen Analgetika. Schweiz Med Wschr. 1955, 85: 746-50.","journal-title":"Schweiz Med Wschr"},{"key":"91_CR4","volume-title":"Phenacetin and renal damage at a Swedish factory","author":"K Grimlund","year":"1963","unstructured":"Grimlund K: Phenacetin and renal damage at a Swedish factory. Edited by: Kungl, Bo ktryckeriet PA. 1963, Norstedt & S\u00f6ner, Stockholm"},{"key":"91_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00005792-199803000-00003","volume":"77","author":"E Delzell","year":"1998","unstructured":"Delzell E, Shapiro S: A review of epidemiologic studies of nonnarcotic analgesics and chronic renal disease. Medicine. 1998, 77: 102-21. 10.1097\/00005792-199803000-00003.","journal-title":"Medicine"},{"key":"91_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1046\/j.1523-1755.1998.00043.x","volume":"54","author":"JK McLaughlin","year":"1998","unstructured":"McLaughlin JK, Lipworth L, Wong-Ho C, Blot WJ: Analgesic use and chronic renal failure: A critical review of the epidemiologic literature. Kidney International. 1998, 54: 679-686. 10.1046\/j.1523-1755.1998.00043.x.","journal-title":"Kidney International"},{"key":"91_CR7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1681\/ASN.V123550","volume":"12","author":"P Michielsen","year":"2001","unstructured":"Michielsen P, Schepper PD: Trends of analgesic nephropathy in two high-endemic regions with different legislation. J Am Soc Nephrol. 2001, 12: 550-56.","journal-title":"J Am Soc Nephrol"},{"key":"91_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0272-6386(96)90046-3","volume":"27","author":"WL Henrich","year":"1996","unstructured":"Henrich WL, Agodoa LE, Barrett B, Bennett WB, Blantz RC, Buckalew VM, D'Agati VD, De Broe ME, Duggin GG, Eknoyan G, Elseviers MM, Gomez RA, Matzke GR, Porter GA, Sabatini S, Stoff J, Striker GE, Winchester JF: National Kidney Foundation Position Paper. Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996, 27: 162-165.","journal-title":"Am J Kidney Dis"},{"key":"91_CR9","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/S0140-6736(05)65350-0","volume":"349","author":"A Tuffs","year":"1996","unstructured":"Tuffs A: German nephrologists demand painkiller ban. Lancet. 1996, 349: 952-10.1016\/S0140-6736(05)65350-0.","journal-title":"Lancet"},{"key":"91_CR10","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1046\/j.1523-1755.2000.00410.x","volume":"58","author":"AR Feinstein","year":"2000","unstructured":"Feinstein AR, Heinemann LAJ, Curhan GC, Delzell E, DeSchepper PJ, Fox JM, Graf H, Luft FC, Michielsen P, Mihatsch MJ, Suissa S, Van der Woude F, Willich S, (ad-hoc review committee): The relationship between non-phenacetin combined analegesics and nephropathy: A review. Kidney Internat. 2000, 58: 2259-2264. 10.1046\/j.1523-1755.2000.00410.x.","journal-title":"Kidney Internat"},{"key":"91_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2369-6-9","volume":"6","author":"LAJ Heinemann","year":"2005","unstructured":"Heinemann LAJ, Garbe E, Lewis M, van der Woude F, Graf H: Case-control study on analgesics and nephropathy (SAN): protocol. BMC Nephrology. 2005, 6: 9-10.1186\/1471-2369-6-9. (8 August 2005)","journal-title":"BMC Nephrology"},{"key":"91_CR12","unstructured":"Website of the SAN study. [http:\/\/www.san-project.com]"},{"key":"91_CR13","unstructured":"FDA Protocol Registration Receipt NCT00302835. [https:\/\/register.clinicaltrials.gov\/app\/prs\/action\/ReleaseProtocol\/ts\/9\/uid]"},{"key":"91_CR14","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0272-6386(03)00647-4","volume":"42","author":"T Kurth","year":"2003","unstructured":"Kurth T, Glynn RJ, Walker AM, Rexrode KM, Buring JE, Stampfer MJ, Hennekens CH, Gaziano JM: Analgesic use and change in kidney function in apparently healthy men. Am J Kidney Dis. 2003, 42: 234-44. 10.1016\/S0272-6386(03)00647-4.","journal-title":"Am J Kidney Dis"},{"key":"91_CR15","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa010323","volume":"345","author":"CM Fored","year":"2001","unstructured":"Fored CM, Ejerblad E, Lindblad P, Fryzek J, Dickman PW, Signorello L, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyren O: Acetaminophen, Aspirin, and chronic renal failure. N Engl J Med. 2001, 345: 1801-08. 10.1056\/NEJMoa010323.","journal-title":"N Engl J Med"},{"issue":"4","key":"91_CR16","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/ndt\/gfl797","volume":"22","author":"P Michielsen","year":"2007","unstructured":"Michielsen P: In memoriam 'analgesic nephropathy' (circa 1972-2006). Nephrol Dial Transplant. 2007, 22 (4): 999-1001. 10.1093\/ndt\/gfl797.","journal-title":"Nephrol Dial Transplant"},{"key":"91_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000168002","volume":"9","author":"W Pommer","year":"1989","unstructured":"Pommer W, Bronder E, Greiser E, Helmert U, Jesdinsky HJ, Klimpel A, Borner K, Molzahn M: Regular analgesic intake and the risk of end-stage renal failure. Am J Nephrol. 1989, 9: 403-12.","journal-title":"Am J Nephrol"},{"key":"91_CR18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2125.1990.tb03841.x","volume":"30","author":"M Morlans","year":"1990","unstructured":"Morlans M, LaPorte J, Vidal X, Cabeza D, Stolley PD: End-stage renal disease and non-narcotic analgesics: a case-control study. Br J Clin Pharmacol. 1990, 30: 717-723.","journal-title":"Br J Clin Pharmacol"},{"key":"91_CR19","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJM198905113201903","volume":"320","author":"DP Sandler","year":"1989","unstructured":"Sandler DP, Smith JC, Weinberg CR, Buckalew VM, Dennis VW, Blythe WB, Burges WP: Analgesic use and chronic renal disease. N Engl J Med. 1989, 320: 1238-43.","journal-title":"N Engl J Med"},{"key":"91_CR20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2105\/AJPH.80.2.153","volume":"80","author":"NK Steenland","year":"1990","unstructured":"Steenland NK, Thun MJ, Ferguson CW, Port FK: Occupational and other exposures associated with male end-stage renal disease. A case-control study. Am J Public Health. 1990, 80: 153-159.","journal-title":"Am J Public Health"},{"key":"91_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","volume":"331","author":"TV Perneger","year":"1994","unstructured":"Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med. 1994, 331: 1675-1679. 10.1056\/NEJM199412223312502.","journal-title":"N Engl J Med"},{"key":"91_CR22","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","volume":"164","author":"GC Curhan","year":"2004","unstructured":"Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ: Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med. 2004, 164: 1519-24. 10.1001\/archinte.164.14.1519.","journal-title":"Arch Intern Med"},{"key":"91_CR23","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/archinte.1983.00350090053009","volume":"143","author":"TG Murray","year":"1983","unstructured":"Murray TG, Stolley PD, Anthony JC, Schinnar R, Hepler-Smith E, Jeffreys JL: Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med. 1983, 143: 1687-1693. 10.1001\/archinte.143.9.1687.","journal-title":"Arch Intern Med"},{"key":"91_CR24","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1111\/j.1523-1755.2005.00346.x","volume":"67","author":"L Ibanez","year":"2005","unstructured":"Ibanez L, Morlans M, Vidal X, Martinez MJ, Laporte JR: Case-control study of regular analgesic and non-steroidal anti-infalammatory use and end-stage renal disease. Kidney International. 2005, 67: 2393-2398. 10.1111\/j.1523-1755.2005.00346.x.","journal-title":"Kidney International"},{"key":"91_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/pds.811","volume":"12","author":"TBM Monster","year":"2003","unstructured":"Monster TBM, de Jong PE, Jong-van den Berg LTW, the PREVEND Study Group: Drug induced renal impairment: a population-based survey. Pharmacoepidemiology Drug Safety. 2003, 12: 135-43. 10.1002\/pds.811.","journal-title":"Pharmacoepidemiology Drug Safety"},{"key":"91_CR26","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1681\/ASN.2005101096","volume":"17","author":"WL Henrich","year":"2006","unstructured":"Henrich WL, Clark RL, Kelly PK, Bukalew VM, Fenves A, Finn WF, Shapiro Ji, Kimmel PL, Eggers P, Agodoa LE, Porter GA, Shapiro S, Toto R, Anderson T, Cupples LA, Kaufman DW: Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: Report of the National Analgesic Nephropathy Study. J Am Soc Nephrol. 2006, 17: 1472-1480. 10.1681\/ASN.2005101096.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"91_CR27","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1093\/ndt\/gfl390","volume":"21","author":"MJ Mihatsch","year":"2006","unstructured":"Mihatsch MJ, Khanlari B, Brunner FP: Obituary to analgesic nephropathy--an autopsy study. Nephrol Dial Transplant. 2006, 21 (11): 3139-3145. 10.1093\/NDT\/GFL 390.","journal-title":"Nephrol Dial Transplant"},{"key":"91_CR28","first-page":"285","volume":"20","author":"MJ Mihatsch","year":"1983","unstructured":"Mihatsch MJ, Hofer HO, Gudat F, Kn\u00fcsli C, Torhorst J, Zollinger HU: Capillary sclerosis of the urinary tract and analgesic nephropathy. Clin Nephrol. 1983, 20: 285-","journal-title":"Clin Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-8-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-8-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:16:32Z","timestamp":1630448192000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-8-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["91"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-8-15","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"29 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}